Tilray Brands (TLRY) Exchange Rate Effect (2017 - 2026)
Tilray Brands (TLRY) posted Exchange Rate Effect of $955000.0 for Q1 2026, up 201.26% on a QoQ basis from $317000.0 in Q4 2025, and up 149.41% year-over-year from $382911.2 in Q1 2025.
Tilray Brands (TLRY) Exchange Rate Effect (2017 - 2026) Analysis & Trends
Tilray Brands' Exchange Rate Effect history runs 10 years deep, the most recent figure standing at $955000.0 for Q1 2026.
- Quarterly Exchange Rate Effect rose 149.41% year-over-year to $955000.0 in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $5.8 million (up 246.71% YoY) and the FY2025 annual result came in at $1.1 million, up 307.1% from the prior year.
- Exchange Rate Effect was $955000.0 for Q1 2026 at Tilray Brands, up from $317000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $4.4 million in Q2 2025 and bottomed at -$2.2 million in Q4 2024.
- A 5-year average of $32705.9 and a median of $188000.0 in 2025 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2024 — Exchange Rate Effect sank 2460.0% — and 2025, when it surged 683.65%.
- Tilray Brands' Exchange Rate Effect stood at -$980000.0 in 2022, then surged by 109.69% to $95000.0 in 2023, then sank by 2460.0% to -$2.2 million in 2024, then jumped by 114.14% to $317000.0 in 2025, then soared by 201.26% to $955000.0 in 2026.
- Business Quant data shows TLRY's Exchange Rate Effect at $955000.0 in Q1 2026, $317000.0 in Q4 2025, and $188000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -17.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 17.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 7.01 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -4.20 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -5.00 Mn |
| 10 | Tilray Brands | 465.02 Mn | 373.06 Mn | 54.95 Mn | 955,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 955,000.00 |
| Feb 28, 2026 | 955,000.00 |
| Nov 30, 2025 | 317,000.00 |
| Nov 30, 2025 | 317,000.00 |
| Aug 31, 2025 | 188,000.00 |
| Aug 31, 2025 | 188,000.00 |
| May 31, 2025 | 4.35 Mn |
| May 31, 2025 | 4.35 Mn |
| Feb 28, 2025 | -1.93 Mn |
| Feb 28, 2025 | -1.93 Mn |
| Nov 30, 2024 | -2.24 Mn |
| Nov 30, 2024 | -2.24 Mn |
| Aug 31, 2024 | 958,000.00 |
| Aug 31, 2024 | 958,000.00 |
| May 31, 2024 | -746,000.00 |
| May 31, 2024 | -746,000.00 |
| Feb 29, 2024 | -512,000.00 |
| Feb 29, 2024 | -512,000.00 |
| Nov 30, 2023 | 95,000.00 |
| Nov 30, 2023 | 95,000.00 |